CAN FITE BIOPHARMA LTD-ADR (CANF) Stock Analyst Ratings
USA - NYSEARCA:CANF - US13471N3008 - ADR
0.4295 USD
-0.01 (-2.16%)
0.41 USD
-0.02 (-4.54%)
ChartMill assigns a Buy % Consensus number of 83% to CANF. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.38. This target is 1384.52% above the current price.
CANF was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CANF.
In the previous month the buy percentage consensus was at a similar level.
CANF was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-16 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-02 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-29 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-15 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-20 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-18 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-03 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-18 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-31 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-05 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-10 | EF Hutton | Maintains | Buy -> Buy |
| 2024-09-24 | EF Hutton | Maintains | Buy -> Buy |
| 2024-08-30 | EF Hutton | Maintains | Buy -> Buy |
| 2024-07-17 | EF Hutton | Initiate | Buy |
| 2024-05-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-06-02 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-13 | HC Wainwright & Co. | Reiterate | Buy |
CAN FITE BIOPHARMA LTD-ADR / CANF FAQ
What do analysts expect the price target to be for CAN FITE BIOPHARMA LTD-ADR (CANF)?
7 analysts have analysed CANF and the average price target is 6.38 USD. This implies a price increase of 1384.52% is expected in the next year compared to the current price of 0.4295.
How do analysts rate CAN FITE BIOPHARMA LTD-ADR (CANF)?
The consensus rating for CAN FITE BIOPHARMA LTD-ADR (CANF) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for CANF stock?
The number of analysts covering CAN FITE BIOPHARMA LTD-ADR (CANF) is 7.